Empowered Funds LLC Sells 29,999 Shares of LifeVantage Co. (NASDAQ:LFVN)

Empowered Funds LLC trimmed its stake in LifeVantage Co. (NASDAQ:LFVN) by 38.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 48,860 shares of the company’s stock after selling 29,999 shares during the quarter. Empowered Funds LLC’s holdings in LifeVantage were worth $857,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Barclays PLC grew its stake in shares of LifeVantage by 38.2% in the third quarter. Barclays PLC now owns 41,966 shares of the company’s stock valued at $507,000 after buying an additional 11,608 shares in the last quarter. HighTower Advisors LLC bought a new stake in LifeVantage during the third quarter worth $638,000. Ritholtz Wealth Management lifted its stake in LifeVantage by 65.2% in the fourth quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock valued at $830,000 after acquiring an additional 18,682 shares during the last quarter. Capital Management Corp VA bought a new position in shares of LifeVantage in the 3rd quarter valued at about $5,073,000. Finally, Copeland Capital Management LLC acquired a new position in shares of LifeVantage during the 4th quarter worth about $65,000. Institutional investors and hedge funds own 35.32% of the company’s stock.

Insider Buying and Selling at LifeVantage

In other news, Director Raymond B. Greer sold 8,000 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $20.15, for a total value of $161,200.00. Following the completion of the sale, the director now owns 99,288 shares of the company’s stock, valued at approximately $2,000,653.20. The trade was a 7.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 20.65% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on LFVN shares. Lake Street Capital started coverage on shares of LifeVantage in a research note on Thursday, December 19th. They issued a “buy” rating and a $26.00 target price for the company. Craig Hallum assumed coverage on LifeVantage in a research note on Tuesday, January 14th. They set a “buy” rating and a $35.00 target price for the company.

LifeVantage Price Performance

Shares of LFVN opened at $18.56 on Tuesday. The firm has a market capitalization of $232.93 million, a PE ratio of 33.14 and a beta of 0.84. The company’s 50-day moving average is $19.78 and its 200-day moving average is $14.28. LifeVantage Co. has a fifty-two week low of $5.22 and a fifty-two week high of $27.38.

LifeVantage (NASDAQ:LFVN) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.08. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be paid a $0.04 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.16 annualized dividend and a yield of 0.86%. LifeVantage’s dividend payout ratio (DPR) is presently 28.57%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.